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PURPOSE. The purpose of this study was to determine retinal hemoglobin oxygen saturation
(SO2) in patients with diabetic retinopathy (DR) using retinal oximetry (RO) and to correlate
the degree of retinal ischemia using intravenous fluorescein angiography (IVFA).
METHODS. This is a single-center cross-sectional cohort study. Twenty-seven controls and 60
adult patients with diabetes mellitus (16 without DR and 44 with DR) were enrolled. Patients
were stratified according to DR severity. Using RO, SO2 was measured in major retinal
arterioles (SaO2) and venules (SvO2). Using IVFA, the percentage of retinal ischemia in 31
patients with DR was calculated and correlated with RO.
RESULTS. Pairwise one-way analysis of variance (ANOVA) showed a significant increase in SaO2
and SvO2 in patients with proliferative DR (PDR) compared with controls (SaO2: PDR, 100 6
7% vs. controls, 91 6 4% [P ¼ 0.003]; SvO2: PDR, 66 6 11% vs. controls, 53 6 6% [P <
0.00001]). The percentage of retinal ischemia also increased with DR severity: ANOVA
showed a significant difference in retinal ischemia between all categories of nonproliferative
DR vs. PDR: 2.31 6 2% vs. 7.92 6 9% (P ¼ 0.017), respectively. Pearson two-tailed
correlation showed significant correlation between SaO2 and ischemia (R ¼ 0.467, P ¼
0.011).
CONCLUSIONS. Hemoglobin oxygen saturation of retinal arterioles and venules increases with
DR severity; SaO2 correlates with increasing ischemia measured by IVFA. Retinal oximetry
may complement current imaging strategies to noninvasively augment the diagnosis and risk
stratification of patients with diabetes.
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Ischemia plays a central role in the pathophysiology ofdiabetic retinopathy (DR). As ischemia increases, untreated
DR generally progresses through four stages in an orderly
fashion: mild nonproliferative DR (NPDR), moderate NPDR,
severe NPDR, and proliferative DR (PDR). Intravenous fluores-
cein angiography (IVFA) is the gold standard to assess retinal
ischemia and perfusion and is also helpful when determining
treatment for DR. However, IVFA is relatively invasive as it
requires the intravenous injection of contrast dye. Furthermore,
IVFA provides only the anatomic state of retinal vessels and
does not give any metabolic information, such as oxygenation.
Recently, quantitative measurement of oxygen saturation
(SO2) has been possible using retinal oximetry (RO), a
noninvasive imaging modality used to estimate hemoglobin
oxygen saturation in retinal arterioles and venules. The
technical aspects of RO have been previously described in
the literature.1–3 Briefly, RO is based on similar principles as
standard pulse oximetry, utilizing the light absorbance of
oxyhemoglobin and deoxyhemoglobin at the carefully selected
wavelengths of 570 and 600 nm. Studies have shown that the
retinal oximeter produces repeatable and reliable measure-
ments when detecting differences in SO2 levels in controls, as
well as in patients with retinal pathology.3–7 Although
normative values for RO have been developed,8–12 less is
known about the measurement of RO in all stages of DR.
Furthermore, prior to our work, the correlation of oxygen
saturation measured by RO (metabolic state) with the
percentage of ischemia assessed by IVFA (anatomic state) was
unknown.
Hence, in this study, we report the retinal vessel oxygena-
tion and perfusion status of patients with diabetes mellitus
(DM) with all stages of DR with two imaging modalities: RO and
IVFA. We also examined differences in arteriolar and venular
hemoglobin oxygenation saturation between controls and
patients with DM.
METHODS
Patients
The study was a single-center cross-sectional cohort. Twenty-
seven controls were enrolled from the University of North
Carolina (UNC) comprehensive ophthalmology clinic, and 60
patients with DM were enrolled from the UNC Retina Clinic
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with the following clinical diagnoses: DM without DR (n¼ 16),
mild NPDR (n¼ 6), moderate NPDR (n¼ 14), severe NPDR (n
¼ 7), and PDR (n¼ 17). The patients were classified according
to the international clinical DR severity scale.13 Inclusion
criteria were at least 18 years of age with type I or type II DM.
Exclusion criteria were patients with a history of retinal
vascular occlusion, glaucoma, and AMD (i.e., ischemic ocular
conditions that could potentially confound the results) and
patients with a media opacity such as dense cataracts or severe
vitreous hemorrhage (i.e., conditions that could obscure RO
images or retinal photographs). Patients with systemic
conditions that could confound RO results were also excluded,
such as severe respiratory disease (e.g., chronic obstructive
pulmonary disease), severe anemia, or sickle cell disease. The
protocol was approved by the UNC Institutional Review Board.
All patients enrolled provided written informed consent, the
study was conducted in accordance to the tenets of the
Declaration of Helsinki, and all work was HIPAA compliant.
Retinal Oximetry
The retinal oximeter consists of a fundus camera with an
attached image splitter, as well as a digital camera (Oxymap T1
device connected to Topcon TRC50-DX fundus camera;
Oxymap ehf., Reykjavik, Iceland). The device captures images
at two wavelengths, one sensitive to oxyhemoglobin (600 nm)
and one isosbestic (570 nm), where the absorption spectra of
oxyhemoglobin and hemoglobin cross. Computer software
detects retinal vessels and uses relative light intensities inside
and outside a vessel to calculate the optical density (light
absorbance) of a vessel at both wavelengths. The hemoglobin
oxygen saturation (SO2) of a vessel can therefore be calculated,
because the optical density ratio at these wavelengths has been
shown to have an approximately inverse linear relationship
with SO2.
1
Prior to image capture, patients’ eyes were dilated with one
drop each of 1% tropicamide and 2.5% phenylephrine. Using
the oximeter, trained retinal photographers obtained images of
both retinas, centered on the optic disc. The images were 1200
3 1600 pixels and covered a 508 field of the central retina.
For each patient, one eye was randomly selected for
analysis. Images were analyzed in a masked fashion by two
independent observers with the Oxymap Analyzer software
(version 2.3.2; Oxymap ehf.), which automatically detects
vessels greater than eight pixels in diameter, using the ring-
method protocol previously described by this research group
(Fig. 1).8 The analysis area was selected by centering quadrant
lines on the optic disc. An initial central circle was used to
delineate the optic disc. Two additional measurement circles,
an inner and outer circle, two and four times the diameter of
the central circle, respectively, were then demarcated. To
exclude the peripheral retina beyond the outer circle and the
optic nerve, only the area between the circles centered on the
optic disc were analyzed. The width of this ring was two disc
diameters. Vessels beyond the area of analysis, certain areas
where vessel detection would prove inaccurate (branching,
overlapping, or intersecting), and segments of vessels less
than 19 pixels in length were excluded. Vessels to be
measured were selected manually. Measurements were first
taken to yield arteriolar SO2 (SaO2) by quadrant. This was
FIGURE 1. Ring method analysis of retinal oximetry images. Image when opened with Oxymap software (top left). Quadrant delineation and circle
outlines in place (top right). Exclusionary areas mapped (bottom left). Overall selection of arterioles (bottom right).
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repeated for venules to yield venular SO2 (SvO2) by quadrant.
Overall saturation was computed by averaging saturation
values of each quadrant. Because Oxymap software measure-
ments are calibrated to nondiabetic young individuals, results
are relative to that calibration, occasionally resulting in SO2
measurements greater than 100%. These values were not
truncated to 100%, per established oximetry protocol.5,8,14
Statistical analyses were implemented with Statistical
Package for the Social Sciences (SPSS) software (version 20.0;
SPSS, Inc., Chicago, IL, USA). One-way analysis of variance
(ANOVA) with Tukey’s post hoc test was used to compare
means, with DR stage as the independent variable and SO2 as
the dependent variable.
Fluorescein Angiography
Ultra-wide field intravenous fluorescein angiography (UWF-
IVFA) is a relatively new diagnostic imaging modality used to
assess retinal perfusion simultaneously in 2008 of the retina.
The photographic equipment consists of a scanning laser
ophthalmoscope that captures rapid sequential images, as well
as separate laser for angiography (Optos 200 Tx; Optos plc.,
Queensferry House, Scotland, United Kingdom). First, approx-
imately 5 mL sodium fluorescein dye that becomes lumines-
cent when excited by certain wavelengths of light (between
465 and 490 nm) is injected intravenously, typically in the
antecubital vein. Fundus images are captured in rapid
sequence to allow the visualization of blood flow through
the retina and choroid.15 In this study, patients with DR were
imaged with UWF- IVFA after RO imaging. The image with
optimal perfusion of dye (approximately 40–50 seconds after
injection) was used for analysis. Because IVFA is relatively
invasive, controls and patients with DM without DR did not
undergo this imaging study.
After accounting for DR patients who were not able to
obtain an IVFA, and patients with poor image quality, 31
patient UWF-IVFA images were analyzed according to the
following protocol. For each patient, the same eye that was
randomly selected for RO analysis was used for IVFA analysis,
using ImageJ Software (Version 1.48v; US National Institutes of
Health, Bethesda, MD, USA) (Fig. 2). The IVFA images were
analyzed by two independent observers who were masked to
patient identity, DR stage, and RO results. Quadrant lines were
transferred from the corresponding RO image analysis to the
IVFA image. An ellipse was delineated to capture the retinal
area (approximately a 4.2-megapixel area) in the image with
the optimal dye perfusion. Nonperfused areas on the image
were manually outlined and measured. The percentage of
retinal ischemia was then calculated by dividing the area of
ischemia by the total delineated elliptical area and multiplying
by 100.
Statistical analyses were performed on the 31 images using
SPSS (version 20.0; SPSS, Inc.). One-way ANOVA with Tukey’s
post hoc test was used to compare means, with DR stage as the
independent variable and percentage of ischemia as the
dependent variable.
FIGURE 2. Fluorescein angiogram image opened in ImageJ software (top left). Quadrants and ellipse in place (top right). Ischemic areas indicated
with yellow arrows (bottom left). Selections of ischemic areas outlined in yellow for pixel measurement (bottom right).
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RESULTS
Patient demographics are summarized in Table 1. A difference
was considered to be significant if the P value was less than
0.05. Overall, ANOVA and v2 tests revealed no significant
difference among the groups regarding age, race, smoking
history, and hemoglobin (Hb)A1c. There was a higher
percentage of patients with hypertension in the diabetes
group than the control group, and the difference was
significant among the groups (P < 0.00001). Statistically, there
was a significant difference among the groups in terms of sex
(P¼ 0.019); however, this is only because there were no males
in the severe NPDR group.
Mean SaO2, SvO2, and arteriovenous differences are
detailed in Table 2. Distribution of the individual patient
values can be visualized in the box and whisker plot of Figure
3. A significant increase in SaO2 was found in patients with
PDR compared with controls (P¼0.003) and patients with DM
without DR (P ¼ 0.001). A significant increase in SvO2 was
found in patients with moderate NPDR compared with
controls (P ¼ 0.038), as well as in PDR patients compared
with controls (P < 0.00001) and DM without DR (P¼ 0.004).
No significant difference was found in SaO2 or SvO2
measurements between any other subgroups. A significant
increase in the arteriovenous difference was also found in
moderate NPDR patients compared with controls (P¼ 0.027).
However, there was not a noticeable trend in arteriovenous
difference with increasing DR severity.
Percentage of retinal ischemia by DR stage were as follows:
mild NPDR, 0.76 6 0.6%; moderate NPDR, 2.21 6 2%; severe
NPDR, 3.50 6 2%; PDR, 7.92 6 9% (Fig. 4). Significance was
found in the percentage of ischemia between all NPDR patients
(2.31 6 2%) and PDR patients (7.92 6 9%; P ¼ 0.017).
Pearson two-tailed correlation analysis demonstrated signif-
icance in the positive correlation between SaO2 and percent-
age of ischemia (R ¼ 0.46, P ¼ 0.011; Fig. 5). However, there
was only a small positive correlation between SvO2 and
percentage of ischemia (R¼ 0.254, P ¼ 0.18; Fig. 5).
DISCUSSION
In this single-center study of 87 participants, we observed the
following. First, RO measurements showed a trend of
increasing arteriolar and venular oxygen saturation with
increasing severity of DR. Retinal arteriolar oxygen saturation
(SaO2) was significantly higher in patients with PDR than in
patients with DM without DR and in controls. Retinal venular
oxygen saturation (SvO2) was significantly higher in patients
with moderate NPDR and PDR than in patients with DM
without DR and in controls. Second, the retinal vessel
oxygenation and perfusion status of patients with DM with
all stages of DR were evaluated with the two imaging
modalities RO and IVFA. We found a trend of increasing retinal
tissue ischemia with increasing severity of DR. We demon-
strated a significant increase in ischemia in patients with PDR
compared with patients with NPDR. Moreover, SaO2 and SvO2
correlated with percentage of ischemia measured by IVFA,
with SaO2 showing a significant correlation.
With respect to RO findings in various stages of DR, this
study adds to the existing literature. Two studies have
demonstrated significantly increased SvO2 and SaO2 in patients
with PDR compared with controls, but did not find trends of
progressively increasing SO2 with severity of disease.
16,17 Two
other studies demonstrated that only SvO2 (and not SaO2)
increased with DR severity.18,19 Khoobehi et al.14 reported
increasing SvO2 and SaO2 with increasing severity of DR and
only found significance in the comparison of controls with
severe NPDR and PDR groups. We observed a similar trend
with increasing disease severity but only determined signifi-
cance in the comparison of controls and DM without DR with
TABLE 1. Demographic Data for Study Patients
Demographic Data
Control
(n ¼ 27)
DM w/o DR
(n ¼ 16)
Mild NPDR
(n ¼ 6)
Moderate NPDR
(n ¼ 14)
Severe NPDR
(n ¼ 7)
PDR
(n ¼ 17)
Age, y* 59 6 9 56 6 10 58 6 19 53 6 10 53 6 11 52 6 12
Sex, no. of male (%)† 9 (33) 6 (38) 5 (83) 9 (94) 0 (0) 6 (35)
Race, no. of patients (%)*
Caucasian 11 (41) 9 (56) 1 (17) 6 (43) 2 (29) 6 (35)
African American 9 (33) 6 (38) 4 (67) 8 (57) 3 (43) 8 (47)
Hispanic 5 (18) 1 (6) – – – 1 (6)
Other 3 (7) – 1 (17) – 2 (29) 2 (12)
HTN, no. of patients (%)‡ 8 (30) 15 (94) 4 (67) 13 (93) 5 (83) 11 (78)
Smoking history, no. of patients (%)* 8 (30) 6 (38) 2 (33) 6 (43) 0 (0) 1 (4)
Hemoglobin A1c (%)* – 7.7 6 2.4 7.6 6 1.2 8.5 6 2.2 8.1 6 1.3 8.3 6 1.6
* No significant difference among groups.
† v2: P¼ 0.019.
‡ v2: P < 0.00001.
TABLE 2. Global Oxygen Saturation Values (%) for Retinal Arterioles, Venules, and the Arteriovenous Difference in Oxygen Saturation for All
Patients, Given as Mean 6 SD (min to max)
Stage Arterioles (SaO2) Venules (SvO2) Arteriovenous (A-V) difference
Normal (n ¼ 27) 91 6 4 (82.5–100.7) 53 6 6 (40.9–64.9) 38 6 5 (29.9–49.1)
DM w/o DR (n ¼ 16) 89 6 8 (66.8–102.0) 53 6 10 (23.4–65.0) 36 6 6 (24.4–43.6)
Mild NPDR (n ¼ 6) 92 6 11 (71.5–102.4) 53 6 14 (34.6–69.1) 39 6 8 (30.6–52.3)
Moderate NPDR (n ¼ 14) 93 6 5 (87.1–99.7) 62 6 6 (53.1–74.4) 31 6 4 (25.3–38.1)
Severe NPDR (n ¼ 7) 96 6 14 (77.0–124.5) 63 6 13 (40.9–76.5) 33 6 11 (21.3–48.4)
PDR (n ¼ 17) 100 6 7 (85.3–112.5) 66 6 11 (40.0–83.4) 34 6 11 (20.2–58.2)
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PDR, as well as the comparison of controls with moderate
NPDR for venular oxygenation.
Additionally, our study is the first to demonstrate correlation
of IVFA with RO in various stages of DR. Our findings are
robust, as we had strict exclusion criteria to exclude those
with either ocular or systemic hypoxia from any cause to
reduce the chances of confounding our RO and IVFA results.
Our observers were masked to patient identity and DR stage to
avoid selection bias. We included all the stages of DR, including
those with DM without DR. Although several studies cited
above included homogeneous populations, we recruited a
multiethnic cohort, thereby increasing the generalizability of
our results. Finally, the novel comparison of RO results was to
the latest generation of ultra-wide field IVFA.
There are two major mechanisms that may explain the
increase in retinal vessel oxygenation and increase in retinal
tissue ischemia in DR: (1) capillary nonperfusion and shunting
and (2) thickening of capillary vessel walls. In capillary
shunting, some vessels dilate and others constrict, leading to
blood flow bypassing parts of the capillary network.20,21 This
leads to capillary nonperfusion, in which blood is quickly
transported through dilated capillaries, reducing the amount of
oxygen provided to retinal tissues. Second, capillary walls
thicken with DR, increasing the distance oxygen must diffuse
FIGURE 3. Assessment of arteriolar oxygen saturation (%) (top left), venular oxygen saturation (%) (top right), and arteriovenous difference in
oxygen saturation (%) (bottom left) for normal, diabetic, and DR patients with increasing severity of disease. Circles indicate outliers.
FIGURE 4. Assessment of tissue ischemia (%) for DR patients with
increasing severity of disease. Circles indicate outliers.
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from the bloodstream to reach retinal tissue.22,23 Blood flow
maldistribution and changes in oxygen extraction could
explain retinal vessel hyperoxia and retinal tissue hypoxia in
later stages of retinopathy. The increase in arteriolar oxygen-
ation may be attributed to an increase in oxygen demand.14 As
retinal tissue becomes ischemic, more blood is directed to the
tissue; therefore, the increase in the oxygenation in the
arterioles. In patients with DM, the decreased extraction of
oxygen results in hyperoxia of the venules as well. In the
central region around the optic nerve, where vessels are in
close apposition, this pathophysiology must also be considered
in the context of counter current exchange, in which oxygen
diffuses directly from arterioles to venules. With increased
blood flow in this region, as in DR, counter current exchange
may become less effective and lead to increased SaO2.
24
The findings of the study should be interpreted in the
context of the following limitations. The study sample size was
small, given the strict exclusion criteria to minimize confound-
ers. This may explain the lack of a significant positive
correlation for ischemia and SvO2; nonetheless, the size and
direction of the correlation coefficient were generally similar
for SvO2 and SaO2. Another limitation is that the that
intravascular O2 saturation approximates tissue O2 saturation
rather than directly measuring the partial pressure of oxygen;
however, at this time, there is no other imaging technology
that gives tissue metabolic information. Other imaging
modalities such as IVFA, optical coherence tomography, and
even the most recent optical coherence tomography angiog-
raphy provide only anatomic information.
The combined use of RO and IVFA to analyze DR severity
has clinical implications. Intravenous fluorescein angiography
is the current standard for qualitative classification of DR.25
Quantitative IVFA could provide standardization for existing
qualitative IVFA studies and could be used in conjunction with
RO to provide not only anatomic staging of DR but also
metabolic staging. Moreover, RO may be used as a tool to help
assess and risk stratify patients with DR noninvasively. The
ability to detect changes in retinal oxygenation, metabolism,
and perfusion could be important for early detection of DR, as
well as potentially monitoring response to therapy in later
stages of DR.
Management of mild DR is typically systemic glycemic and
blood pressure control until a patient presents with advanced
disease, such as PDR. Quantifying the ischemia in IVFA
imaging, we found that ischemia significantly increased in
PDR compared with all stages of NPDR. Similarly, we found
that SaO2 and SvO2 significantly increased from controls to
patients with PDR. The study showed the range of RO values
that are concerning for a patient with severity of disease that
calls for targeted management and has correlated these values
with an increase in tissue ischemia. Thus, significant findings
for both imaging methods were established for PDR, the
severity of DR that requires active treatment.
In conclusion, this study found a significant correlation
between stage of DR and RO and was the first to correlate RO
with IVFA. Further longitudinal studies are needed to
determine the role of RO in risk-stratifying patients for
progression of DR and investigate the effect of DR treatments
on retinal oxygenation. Although larger studies are needed to
confirm our findings, we hope that in the future, RO may
ultimately become not only a scientific tool to evaluate the role
of oxygen in human retinal pathology but also a clinical tool to
diagnose DR and monitor retinal disease progression, as well as
response to treatments.
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